- Saudi Arabia
Opening
Prof. Hafez Ghanem
SESSION I
Chairpersons : Dr. Sami Alshammary , Dr. Rami Faraj, Dr. Hasan M. Alkhudairi
6:00 – 6:15
Role of Antibiotic at EOL
Dr. Nabil Al Moalami
6:15 – 6:30
Management of terminal Delirium
Dr. Maria Aljehani
6:30 – 6:45
Refractory seizure in brain metastasis
Dr. Waleed Bukhari
6:45 – 7:00
Pons and cons of opioid withdrawing in patient with coma
Dr. Mohamad Hamadeh
7:00 – 7:15
Discussion
7:15 – 7:30
Break
SESSION II
Moderators: Prof. Hafez Ghanem, Dr. Gomaa Abdelfattah , Dr. Abdullah Alshehri
7:30 – 7:45
Debates about Palliative sedation
Dr. Eman Bukhari
7:45 – 8:00
Role of VTE prophylaxis in palliative patients
Dr. Abdullah Alsuhail
8:00 – 8:15
Q&A in cancer patients with cachexia
Dr. Omnia Alyasi
8:15 – 8:30
Insomnia in terminally ill patients
Dr. Mohamad Hemeish
8:30 – 8:45
Benefit and limitation of CNS stimulant in treating fatigue
Dr. Taher Karriri
8:45 – 9:00
Discussion
9:00 – 9:30
SATELLITE SYMPOSIUM (Janssen)
9:30 – 10:30
DINNER
SESSION I: GU cancers
8:30 - 9:00
Sequencing of Systemic Therapy in Advanced Prostate Cancer
Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Mubarak Almansour, Dr. Abdullah Alsharm, Dr. Faisal Albadainah, Dr. Jawaher Ansari, Dr. Rula Almufti, Dr. Amin Eltigani
Moderator: Dr. Emad Tashkandi
09:00 - 9:30
Advanced Bladder Cancer: Optimal Therapeutic Strategy
Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Abdullah Alsharm, Dr. Faisal Albadainah, Dr. Jawaher Ansari, Dr. Rula Almufti, Dr. Emad Tashkandi, Dr. Amin Eltigani
Moderator: Dr. Mubarak Almansour
SESSION II: Brain Germinoma
09:30 - 10:00
Therapeutic Challenges
Panel: Dr. Hussien Khalid, Dr. Hani Elkhatib, Dr. Mubarak Almansour, Dr. Faisal Albadainah, Dr. Rula Almufti, Dr. Emad Tashkandi, Dr. Ibrahim Madkhali, Dr. Nasser Al-Dhaibani
Moderator: Dr. Abdullah Alsharm
10:00 - 10:30
Satellite Symposium (Novartis)
10:30 - 10:40
Break
SESSION III: Breast Cancer
Breast Sarcoma: Challenges and Therapeutic Recommendations
10:40 - 11:20
Adjuvant therapy in low ER+/HER2 negative BC CDK4-6 inhibitors+hormonal therapy in metastatic low ER+/HER2-negative or ER-negative/PR+ve breast cancer Adjuvant CDK4-6 inhibitors in node-negative breast cancer
Panel: Dr. Esam Murshid, Dr. Abdulrahman Alshehri, Dr. Sherif kullab, Dr. Atlal Abusanad, Dr. Maha Alidrisi, Dr. Nasser Al-Dhaibani , Dr. Mariam Alsulami, Dr. Emad Alsharif
Moderator: Ahmed Zeeneldin
11:20 - 12:00
Opening Ceremony
12:00 - 13:45
Prayer& Lunch
13:45 - 14:15
Satellite Symposium (MSD)
Session IV: Breast Cancer
CDK4/6 inhibitors post progression- YES/NO
14:15 - 14:30
CDK4/6 inhibitors post progression- YES
Dr. Khalid AlSaleh
14:30 - 14:45
CDK4-6 inhibitors post progression- NO
Dr. Mohamed Awad
14:45 - 15:00
Panel discussion:
Panel discussion: Dr. Khalid Alsaleh, Dr. Mohamed Awad Ebrahim, Dr. Majid Aljahel, Dr. Bassam Basulaiman
Moderator: Dr. Sherif kullab
SESSION V: Breast Cancer
Hormonal-based therapy in HR+/HER2- BC
15:00 - 15:30
Adjuvant therapy in low ER+/HER2 negative BC CDK4-6 inhibitors+hormonal therapy in metastatic low ER+/HER2-negative or ER-negative/PR+ve breast cancer Adjuvant CDK4-6 inhibitors in node-negative breast cancer
Panel: Dr. Ahmed Alshehri, Dr. Khalid Alsaleh, Dr. Bassam Basulaiman, Dr. Mohamed Ali, Dr. Shereen Elshorbagy, Dr. Shereef Elsamany, Dr. Omima Elemam
Moderator: Dr. Adher Alsayed
15:30 - 15:40
Break
SESSION VI: Breast Cancer
HER2-low/ultra-low; Pathological and clinical perspectives?
15:40 - 16:10
Cutoff low vs. ultra-low?? Which staining platform??
Can we use TDX-D without HER2-testing?
How to choose between available ADCs?
Panel: Dr. Ahmed Alfaraj, Dr. Ahmed Zeeneldine, Dr. Ibtessam Saadeldin , Dr. Atlal Abusanad, Dr. Majid Aljahel, Dr. Mohamed Awad Ebrahim, Dr. Sherif kullab, Dr. Rasha Haggag
Moderators: Dr. Hatim Al Maghrabi Dr. Aboelkhair Algahami
SESSION VII: Breast Cancer
Adjuvant therapy in TNBC
16:10 - 16:40
Adjuvant immunotherapy after NAC without immunotherapy Adjuvant carboplatin after upfront surgery: Yes/No Adjuvant immunotherapy in case of pCR Adjuvant capecitabine: Basal vs. Non-basal TNBC
Panel: Dr. Esam Murshid, Dr. Bassam Basulaiman, Dr. Abdulrahman Alshehri, Dr. Ahmed Alfaraj, Dr. Aboelkhair Algahami, Dr. Atlal Abusanad, Dr. Adher Alsayed, Dr. Mohamed Ali
Moderators: Dr. Ahmed Alshehri
16:40 - 17:00
Break
Session IX: Breast Cancer
Consensus Panel of the management of early lobular BC
17:00 - 17:40
Panel
Dr. Esam Murshid, Dr. Ahmed Alshehri, Dr. Ahmed Alfaraj, Dr. Abdulrahman Alshehri, Dr. Ahmed Zeeneldine, Dr. Mohamed Awad Ebrahim, Dr. Khalid Alsaleh, Dr. Ibtessam Saadeldin, Dr. Adher Alsayed, Dr. Shereen Elshorbagy, Dr. Khaled Galal
Moderator: Dr. Shereef Elsamany
Day 2 Conclusion
Session I: Eosophageal cancer
Adenocarcinoma of the esophagus: What we know and what we do not know?
08:30 - 09:00
Satellite Symposium (Merck)
09:00 - 09:40
CROSS and adjuvant nivolumab vs FLOT
When to use CROSS approach
TNT in esophageal cancer
Adjuvant nivolumab after definitive chemoRT
Panel: Dr. Teresa Macarulla, Dr. Hani Eltaani, Dr. Fahad Ibnshamsah, Dr. Marwan AlHajeili, Dr. Ruaa Shafi, Dr. Kanan Alshammari, Dr. Maha Alidrisi, Dr. Faiz AlShafa, Dr. Nasser Saleh
Moderator: Dr. Mervat Mahrous
Session II: Perioperative therapy in Gastric Cancer
09:40-10:20
- Adjuvant therapy in case of no/limited response after preoperative FLOT -Perioperative therapy in MSI-H gastric cancer - Perioperative immunotherapy in gastric cancer Perioperative therapy in HER2+ gastric cancer
Panel: Dr. Turki Alfayea, Dr. Ali Alqahtani, Dr. Mohammed Bayamin, Dr. Fahad Ibnshamsah, Dr. Waleed AlSelwi, Dr. Ali Alfakeeh, Dr. Mohammad Algarni, Dr. Fahad Almugbel, Dr. Kamel Farag
Moderator: Dr. Ali Aljubran
SESSION III: Hepatobiliary cancers
Combining local and systemic therapy in HCC
09:50-10:30
Panel: Prof. Gamal Esmat, Dr. Adnan Alzanbagi, Dr. Waleed AlSelwi, Dr. Mervat Mahrous, Dr. Turki Alfayea, Dr. Kanan Alshammari, Dr. Ruaa Shafi, Dr. Mohammad Algarni
Moderator: Dr. Shereef Elsamany
10:30-11:00
Satellite Symposium (GSK)
SESSION IV: Gyne-Oncology
HIPEC in ovarian cancer
11:30 - 12:10
Panel: Dr. Abdulaziz Alzahrani, Dr. Ahmed Refae, Dr. Ehab Elnakoury, Dr. Basel Refky, Dr. Omima Elemam, Prof. Ahmed Badheeb, Dr. Saleh Alzahrani
Moderator: Dr. Waleed Bahaj
Neoadjuvant therapy in MSI-H colon cancer: Yes/No
12:10 - 12:30
Neoadjuvant therapy in colon cancer: Yes/No
Dr. Teresa Macarulla
12:30 - 12:45
Discussion
Panel: Dr. Kamel Farag, Dr. Sakher Abdullah, Dr. Saleh Alzahrani, Dr. Ehab El Hosseny, Prof. Maha Elzaafarany
Moderator: Dr. Ahmed Refae
12:45 - 13:30
Case-based presentation CRC with peritoneal metastasis: HIPEC/No HIPEC
Panel: Dr. Teresa Macarulla, Dr. Ali Alfakeeh, Dr. Marwan AlHajeili, Dr. Ali Aljubran, Dr. Fahad Almugbel, Dr. Abdulaziz Alzahrani, Dr. Ehab El Hosseny, Dr. Saleh Alzahrani
Moderator: Dr. Ali Alqahtani
13:30 - 13:35
CONCLUSION
Contact Us